TRACE RA

Trial Name: TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis

Chief Investigator: Professor George Kitas

Principal Investigators: Professor Deborah Symmons and Professor Jill Belch

Trial Description: Multi-centre, randomised, double blind, placebo-controlled trial

Background: Rheumatoid Arthritis (RA) is a severe, progressive disorder associated with increased and premature cardiovascular mortality. This study aims to assess if the statin Atrovastin will protect RA patients from atherosclerotic events.

Main Outcomes: To determine the effects of Atrovastatin on cardiovascular events and mortality in RA patients.

Patients recruited: 3808

Status: Completed

CTU: N/A

Funder: Arthritis Research Campaign and the British Heart Foundation

Further Information: g.d.kitas@bham.ac.uk

ISRCTN number: 41829447

To view the protocol please click here.